Ani Pharmaceuticals (ANIP) EBITDA Margin (2011 - 2026)
Ani Pharmaceuticals (ANIP) reported EBITDA Margin of 22.72% for Q2 2026, up 4.98 percentage points from 17.75% a year earlier but down 2.61 percentage points from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EBITDA Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ani Pharmaceuticals' EBITDA Margin came in at 24.28%, up 10.79 percentage points year-over-year; for FY2025, it came in at 23.08%, up 11.85 percentage points from FY2024.
- EBITDA Margin has a five-year change of +8.45 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 11.22% in FY2024 (-11.51 pp), 22.74% in FY2023 (+13.78 pp), 8.95% in FY2022 (+4.34 pp) and 4.61% in FY2021 (-10.02 pp).
- Five-year quarterly EBITDA Margin spans a low of -15.17% in Q4 2021 and a high of 25.99% in Q3 2025.
- Year over year, EBITDA Margin has now increased in each of the last five quarters, with an average year-over-year change of +1.76 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q4 2022 (a gain of 34.69 percentage points); the low point was Q4 2021 (a drop of 35.82 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 25.34% (Q1 2026), 23.37% (Q4 2025) and 25.99% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 42.49% |
| 10 | Ani Pharmaceuticals | 1.43 Bn | 212.92 Mn | 165.89 Mn | 22.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.72% |
| Mar 31, 2026 | 25.34% |
| Dec 31, 2025 | 23.37% |
| Sep 30, 2025 | 25.99% |
| Jun 30, 2025 | 17.75% |
| Mar 31, 2025 | 25.07% |
| Dec 31, 2024 | 9.73% |
| Sep 30, 2024 | -3.13% |
| Jun 30, 2024 | 14.82% |
| Mar 31, 2024 | 25.54% |
| Dec 31, 2023 | 17.37% |
| Sep 30, 2023 | 25.60% |
| Jun 30, 2023 | 23.75% |
| Mar 31, 2023 | 23.96% |
| Dec 31, 2022 | 19.52% |
| Sep 30, 2022 | 11.65% |
| Jun 30, 2022 | 1.95% |
| Mar 31, 2022 | -5.67% |
| Dec 31, 2021 | -15.17% |
| Sep 30, 2021 | 16.06% |
API Access
Ani Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();